BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 22545573)

  • 1. Routine delivery of artemisinin-based combination treatment at fixed health facilities reduces malaria prevalence in Tanzania: an observational study.
    Khatib RA; Skarbinski J; Njau JD; Goodman CA; Elling BF; Kahigwa E; Roberts JM; MacArthur JR; Gutman JR; Kabanywanyi AM; Smith EE; Somi MF; Lyimo T; Mwita A; Genton B; Tanner M; Mills A; Mshinda H; Bloland PB; Abdulla SM; Kachur SP
    Malar J; 2012 Apr; 11():140. PubMed ID: 22545573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artemisinin-based combination therapy does not measurably reduce human infectiousness to vectors in a setting of intense malaria transmission.
    Huho BJ; Killeen GF; Ferguson HM; Tami A; Lengeler C; Charlwood JD; Kihonda A; Kihonda J; Kachur SP; Smith TA; Abdulla SM
    Malar J; 2012 Apr; 11():118. PubMed ID: 22513162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cluster-randomized trial of mass drug administration with a gametocytocidal drug combination to interrupt malaria transmission in a low endemic area in Tanzania.
    Shekalaghe SA; Drakeley C; van den Bosch S; ter Braak R; van den Bijllaardt W; Mwanziva C; Semvua S; Masokoto A; Mosha F; Teelen K; Hermsen R; Okell L; Gosling R; Sauerwein R; Bousema T
    Malar J; 2011 Aug; 10():247. PubMed ID: 21864343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial.
    von Seidlein L; Milligan P; Pinder M; Bojang K; Anyalebechi C; Gosling R; Coleman R; Ude JI; Sadiq A; Duraisingh M; Warhurst D; Alloueche A; Targett G; McAdam K; Greenwood B; Walraven G; Olliaro P; Doherty T
    Lancet; 2000 Jan; 355(9201):352-7. PubMed ID: 10665554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity.
    Okell LC; Drakeley CJ; Bousema T; Whitty CJ; Ghani AC
    PLoS Med; 2008 Nov; 5(11):e226; discussion e226. PubMed ID: 19067479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes.
    Atroosh WM; Al-Mekhlafi HM; Snounou G; Al-Jasari A; Sady H; Nasr NA; Lau YL; Surin J
    Malar J; 2016 May; 15(1):295. PubMed ID: 27234587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate.
    Shekalaghe S; Drakeley C; Gosling R; Ndaro A; van Meegeren M; Enevold A; Alifrangis M; Mosha F; Sauerwein R; Bousema T
    PLoS One; 2007 Oct; 2(10):e1023. PubMed ID: 17925871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of malaria prevalence after introduction of artemisinin-combination-therapy in Mbeya Region, Tanzania: results from a cohort study with 6773 participants.
    Froeschl G; Saathoff E; Kroidl I; Berens-Riha N; Clowes P; Maboko L; Assisya W; Mwalongo W; Gerhardt M; Ntinginya EN; Hoelscher M
    Malar J; 2018 Jun; 17(1):245. PubMed ID: 29940968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria during pregnancy and pregnancy outcomes: a cross-sectional study in Geita district, North-Western Tanzania.
    Mpogoro FJ; Matovelo D; Dosani A; Ngallaba S; Mugono M; Mazigo HD
    Malar J; 2014 Nov; 13():455. PubMed ID: 25421496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primaquine for reducing Plasmodium falciparum transmission.
    Graves PM; Gelband H; Garner P
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008152. PubMed ID: 22972117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of combining intermittent preventive treatment with home management of malaria in children less than 10 years in a rural area of Senegal: a cluster randomized trial.
    Tine RC; Faye B; Ndour CT; Ndiaye JL; Ndiaye M; Bassene C; Magnussen P; Bygbjerg IC; Sylla K; Ndour JD; Gaye O
    Malar J; 2011 Dec; 10():358. PubMed ID: 22166001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmodium falciparum gametocyte dynamics in areas of different malaria endemicity.
    Stepniewska K; Price RN; Sutherland CJ; Drakeley CJ; von Seidlein L; Nosten F; White NJ
    Malar J; 2008 Dec; 7():249. PubMed ID: 19055751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High efficacy of two artemisinin-based combinations: artesunate + sulfadoxine-pyrimethamine and artemether-lumefantrine for falciparum malaria in Yemen.
    Adeel AA; Saeed NA; Aljasari A; Almohager AM; Galab MH; AlMahdi A; Mahammed MH; AlDarsi M; Salaeah YA; Atta H; Zamani G; Warsame M; Barrette A; Mohammady HE; Nada RA
    Malar J; 2015 Nov; 14():449. PubMed ID: 26573814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized open-label trial of artesunate- sulfadoxine-pyrimethamine with or without primaquine for elimination of sub-microscopic P. falciparum parasitaemia and gametocyte carriage in eastern Sudan.
    El-Sayed B; El-Zaki SE; Babiker H; Gadalla N; Ageep T; Mansour F; Baraka O; Milligan P; Babiker A
    PLoS One; 2007 Dec; 2(12):e1311. PubMed ID: 18074034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali.
    Kayentao K; Maiga H; Newman RD; McMorrow ML; Hoppe A; Yattara O; Traore H; Kone Y; Guirou EA; Saye R; Traore B; Djimde A; Doumbo OK
    Malar J; 2009 Jan; 8():5. PubMed ID: 19128455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial.
    Mwaiswelo R; Ngasala B; Jovel I; Aydin-Schmidt B; Gosling R; Premji Z; Mmbando B; Björkman A; Mårtensson A
    Malar J; 2016 Aug; 15(1):435. PubMed ID: 27565897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (Sub)microscopic Plasmodium falciparum gametocytaemia in Kenyan children after treatment with sulphadoxine-pyrimethamine monotherapy or in combination with artesunate.
    Schneider P; Bousema T; Omar S; Gouagna L; Sawa P; Schallig H; Sauerwein R
    Int J Parasitol; 2006 Apr; 36(4):403-8. PubMed ID: 16500657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of two artemisinin combination therapies for uncomplicated falciparum malaria in children under 5 years, Malakal, Upper Nile, Sudan.
    van den Broek I; Amsalu R; Balasegaram M; Hepple P; Alemu E; Hussein el B; Al-Faith M; Montgomery J; Checchi F
    Malar J; 2005 Feb; 4():14. PubMed ID: 15730557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artemisinin-naphthoquine combination (ARCO) therapy for uncomplicated falciparum malaria in adults of Papua New Guinea: a preliminary report on safety and efficacy.
    Hombhanje FW; Linge D; Saweri A; Kuanch C; Jones R; Toraso S; Geita J; Masta A; Kevau I; Hiawalyer G; Sapuri M
    Malar J; 2009 Aug; 8():196. PubMed ID: 19671190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs.
    Bousema T; Okell L; Shekalaghe S; Griffin JT; Omar S; Sawa P; Sutherland C; Sauerwein R; Ghani AC; Drakeley C
    Malar J; 2010 May; 9():136. PubMed ID: 20497536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.